Nxera Pharma Co (SOLTF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 20 44 sessions, November 17, 2025 to November 5, 2026
- Largest daily move
- +60.9% close of September 3, 2026
- 1-month change
- +39.8% closing prices, September 29, 2026 to November 5, 2026
Company Description
Nxera Pharma Co (OTC: SOLTF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $998.3M.
SOLTF has gained 39.8% over the past month. The last closing price was $10.93.
This page collects what Stock Titan holds for SOLTF, including price data, latest news, and short interest trends.
Stock Performance
Nxera Pharma Co (SOLTF) closed at $10.93 on November 5, 2026. Over the past month, the price has gained 39.8%.
SOLTF Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Nxera Pharma Co has 8 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include earnings, AI, clinical trial, management. View all SOLTF news →
SEC Filings
Short Interest History
Short interest in Nxera Pharma Co (SOLTF) currently stands at 1.7 million shares, up 0.7% from the previous reporting period, representing 2.3% of the float.
Days to Cover History
Days to cover for Nxera Pharma Co (SOLTF) currently stands at 1000.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 126.8 to 1000.0 days.
SOLTF Company Profile & Sector Positioning
Nxera Pharma Co (SOLTF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing SOLTF often look at related companies in the same sector, including Inventiva SA ACT Porteur (IVEVF), Pharming Group NV (PHGUF), Oxford Biomedica plc New (OXBDF), DBV Technologies SA (DBVTF), and Pharma Mar SA New (PHMMF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SOLTF's relative position within its industry.